ImmunoGen down on GSK deal renegotiations

IMGN was off $1.83 (46%) to $2.15 on 5 million shares on

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE